Cost-effectiveness analysis of colorectal cancer treatments

被引：24

作者：

van den Hout, WB

van den Brink, M

Stiggelbout, AM

van de Velde, CJH

Kievit, J

机构：

[1] Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands

[2] Leiden Univ, Med Ctr, Dept Surg Oncol, NL-2300 RC Leiden, Netherlands

来源：

EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷 / 07期

关键词：

cost-effectiveness analysis; methodology; survey; colorectal cancer;

D O I：

10.1016/S0959-8049(02)00053-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A concise overview is provided of the methodology of cost-effectiveness analyses, followed by a survey of published CEAs of colorectal cancer treatments. To gain credibility, the methodology applied in CEAs must be further improved. Costs are rarely estimated from the societal perspective, and little is known about how colorectal patients value their treatment and health. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：953 / 963

页数：11

共 45 条

[1] Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy [J].